New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity

被引：8

作者：

Gupta, RA

DuBois, RN ^{[1
]}

Wallace, MC

机构：

[1] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN 37232 USA

[2] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2002年 / 16卷 / 06期

关键词：

cyclo-oxygenase; colon cancer; prevention; angiogenesis;

D O I：

10.1053/bega.2002.0353

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Carcinoma of the colon and/or rectum represents the second most common gastrointestinal malignancy worldwide. Despite this prevalence, current therapeutic regimens remain largely ineffectual, particularly when the disease is diagnosed at an advanced stage. Recent work in the field of colorectal cancer has established that a chronic intake of non steroidal anti-inflammatory drugs can reduce the risk of developing colorectal cancer. Although the precise mechanism(s) by which these drugs inhibit tumour growth is not completely understood, it is likely that at least a part of their anti-tumorigenic effects results from an inhibition of the cyclo-oxygenase-2 enzyme. This chapter will focus on this emerging research area and the promise it brings for identifying new strategies for the prevention of colorectal cancer.

引用

收藏

页码：945 / 956

页数：12

相关论文

共 48 条

[31] Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs [J].

Smalley, WE ;

Griffin, MR ;

Fought, RL ;

Ray, WA .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (08) :461-469

[32] Cyclooxygenases: Structural, cellular, and molecular biology [J].

Smith, WL ;

DeWitt, DL ;

Garavito, RM .

ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 :145-182

[33] Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice [J].

Sonoshita, M ;

Takaku, K ;

Sasaki, N ;

Sugimoto, Y ;

Ushikubi, F ;

Narumiya, S ;

Oshima, M ;

Taketo, MM .

NATURE MEDICINE, 2001, 7 (09) :1048-1051

[34] The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis [J].

Steinbach, G ;

Lynch, PM ;

Phillips, RKS ;

Wallace, MH ;

Hawk, E ;

Gordon, GB ;

Wakabayashi, N ;

Saunders, B ;

Shen, Y ;

Fujimura, T ;

Su, LK ;

Levin, B ;

Godio, L ;

Patterson, S ;

Rodriguez-Bigas, MA ;

Jester, SL ;

King, KL ;

Schumacher, M ;

Abbruzzese, J ;

DuBois, RN ;

Hittelman, WN ;

Zimmerman, S ;

Sherman, JW ;

Kelloff, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) :1946-1952

[35] Aspirin use and colorectal cancer:: Post-trial follow-up data from the Physicians' Health Study [J].

Stürmer, T ;

Glynn, RJ ;

Lee, IM ;

Manson, JE ;

Buring, JE ;

Hennekens, CH .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (09) :713-+

[36] ASPIRIN USE AND REDUCED RISK OF FATAL COLON CANCER [J].

THUN, MJ ;

NAMBOODIRI, MM ;

HEATH, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1593-1596

[37] Combinatorial chemoprevention of intestinal neoplasia [J].

Torrance, CJ ;

Jackson, PE ;

Montgomery, E ;

Kinzler, KW ;

Vogelstein, B ;

Wissner, A ;

Nunes, M ;

Frost, P ;

Discafani, CM .

NATURE MEDICINE, 2000, 6 (09) :1024-1028

[38] Cyclooxygenase regulates angiogenesis induced by colon cancer cells [J].

Tsujii, M ;

Kawano, S ;

Tsuji, S ;

Sawaoka, H ;

Hori, M ;

DuBois, RN .

CELL, 1998, 93 (05) :705-716

[39] SULINDAC FOR POLYPOSIS OF THE COLON [J].

WADDELL, WR ;

GANSER, GF ;

CERISE, EJ ;

LOUGHRY, RW .

AMERICAN JOURNAL OF SURGERY, 1989, 157 (01) :175-179

[40] The role of COX-2 in intestinal cancer [J].

Williams, C ;

Shattuck-Brandt, RL ;

DuBois, RN .

CANCER PREVENTION: NOVEL NUTRIENT AND PHARMACEUTICAL DEVELOPMENTS, 1999, 889 :72-83

← 1 2 3 4 5 →